Zacks analyst blog spotlights Accenture, SAP, The Estee Lauder, CME Group and Aon

For immediate release

Chicago, IL – June 7, 2022 – Zacks.com announces the list of stocks featured in the analyst blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Stocks recently featured in the blog include: Accenture plc ACN, SAP SE SAP, The Estée Lauder Companies Inc. EL, CME Group Inc. CME and Aon plc AON.

Here are the highlights from Monday’s analyst blog:

Key analyst reports for Accenture, SAP and Estee Lauder

Zacks Research Daily features top research results from our team of analysts. Today’s Research Daily features new research reports on 16 major stocks, including Accenture plc, SAP SE and The Estée Lauder Companies Inc. These research reports have been handpicked from over 70 reports published by our analyst team today.

You can see all today’s research reports here >>>

Accenture stocks have gained +9.3% over the past year, roughly matching the +10.2% gain in the Zacks advisory services sector, but larger in magnitude than the -3 decline, 7% of the broad market. The Zacks analyst believes the company is steadily gaining ground in its outsourcing and consulting businesses.

The company has strategically enhanced its cloud and digital marketing suite through buyouts and partnerships. The company’s strong operating cash flow has helped it reward its shareholders in the form of dividend payouts and share buybacks, and seize opportunities in areas that show real potential.

However, on the other hand, pricing pressure due to significant competition from strong companies like Genpact, Cognizant and Infosys, remains a concern. The global presence exposes it to exchange rate fluctuations. Integration risks related to the takeover remain a concern.

(You can read the full Accenture research report here >>>)

SAP shares are down -26.4% year-to-date against the -21.2% drop in the industry Zacks Computer – Software. The Zacks analyst believes the company’s low adoption of software licensing and support offerings remains a headwind. Fierce competition and rising costs to improve cloud-based offerings will likely put pressure on the company’s profitability, at least in the short term.

Although the suspension of Russian operations amid the ongoing war in Ukraine is expected to affect both revenue and non-IFRS operating profit, the company reiterated its outlook for 2022. Nonetheless, the company’s performance is gaining strong in its cloud business, especially the new SAP solution. The momentum of the SAP Business Process Intelligence platform, particularly S/4HANA solutions, as well as the consistent traction seen in SuccessFactors Employee Central, Ariba and Fieldglass, Qualtrics and other cloud-based offerings are noteworthy.

(You can read the full SAP research report here >>>)

The Estee Lauder shares have outperformed the industry of Zacks Cosmetics over the past two years (+31.0% vs -10.2%). The Zacks analyst believes the company is benefiting from its growing skincare portfolio. The company’s strong presence in emerging markets has also been a driver.

Additionally, its online business is robust and the company expects it to be a major growth driver for the next few years. These benefits were visible in the company’s third quarter fiscal 2022 results, in which both revenue and net income increased year over year.

However, the company is struggling with pandemic-induced restrictions in the Asia/Pacific region. During the third quarter, organic sales fell to mid-single digits in mainland China as a sharp decline in physical sales offset online growth. The company has downgraded its outlook for fiscal 2022 due to additional headwinds affecting the fiscal fourth quarter outlook.

(You can read the full research report on The Estee Lauder here >>>)

Other noteworthy reports we feature today include CME Group Inc. and Aon plc.

Why haven’t you watched Zacks best action?

Our top 5 performing strategies swept away the S&P’s impressive +28.8% gain in 2021. Surprisingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today, you can access their live selections at no cost or obligation.

See Free Stocks >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

https://www.zacks.com

Past performance is not indicative of future results. The potential for loss is inherent in any investment. This document is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether any investment is suitable for any particular investor. It should not be assumed that investments in the securities, companies, sectors or markets identified and described have been or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management of securities. These returns come from hypothetical portfolios composed of stocks with Zacks Rank = 1 that have been rebalanced monthly without transaction fees. These are not the returns of actual stock portfolios. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for more information on the performance figures displayed in this press release.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could jump in at any moment.

This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.

Free: See our best stock and our 4 finalists >>

Click to get this free report

CME Group Inc. (CME): Free Stock Analysis Report

Accenture PLC (ACN): Free Inventory Analysis Report

SAP SE (SAP): Free Inventory Analysis Report

The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report

Aon plc (AON): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Comments are closed.